Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC49429 6-keto Lithocholic Acid

    3Α-羟基-6K-5Β-胆甾烷-24-酸

    A metabolite of lithocholic acid
  3. GC49426 Taurine-d4

    牛磺酸-D4,2-Aminoethanesulfonic acid-d4

    An internal standard for the quantification of taurine
  4. GC49425 Simazine-d10

    十氘代西玛嗪

    An internal standard for the quantification of simazine
  5. GC49415 Capsorubin

    辣椒紫紅素

    A carotenoid with diverse biological activities
  6. GC49412 NSC 756093 An inhibitor of the GBP1-Pim-1 protein-protein interaction
  7. GC49403 Benzarone

    苯扎隆,Fragivix

    An active metabolite of benzbromarone
  8. GC49401 Triptolide-d3

    PG490-d3

    Triptolide-d3 (PG490-d3) 是氘标记的雷公藤内酯。雷公藤内酯是从雷公藤根中提取的二萜类三环氧化物,具有免疫抑制、抗炎、抗增殖和抗肿瘤作用。雷公藤内酯是一种 NF-κB 活化抑制剂。
  9. GC49393 all-trans-13,14-Dihydroretinol A metabolite of all-trans retinoic acid
  10. GC49372 Kaempferol 7-neohesperidoside

    山柰酚-7-O-新橙皮糖苷

    A flavonoid glycoside with antioxidant and anticancer activities
  11. GC49344 Fisetin-d5 An internal standard for the quantification of fisetin
  12. GC49329 Turkesterone (hydrate) A phytoecdysteroid with diverse biological activities
  13. GC49314 Arecaidine propargyl ester (hydrobromide)

    1,2,5,6-四氢-1-甲基-3-吡啶羧酸2-丙炔-1-基酯氢溴酸盐

    A muscarinic M2 agonist
  14. GC49308 Ungeremine

    石蒜碱内铵盐

    A betaine-type alkaloid with diverse biological activities
  15. GC49303 Ganoderic Acid DM

    灵芝酸 DM

    A triterpenoid with diverse biological activities
  16. GC49275 8-Oxycoptisine

    8-氧黄连碱

    An isoquinoline alkaloid with anticancer and gastroprotective activities
  17. GC49270 Nicotinamide-d4

    氘代烟酰胺,Niacinamide-d4; Nicotinic acid amide-d4

    An internal standard for the quantification of nicotinamide
  18. GC49268 (+)-δ-Cadinene

    Δ-杜松烯

    A sesquiterpene with antimicrobial and anticancer activities
  19. GC49259 Antagonist G (trifluoroacetate salt)

    Arg-D-Trp-NmePhe-D-Trp-Leu-Met-NH2, Arg6,D-Trp7,9,NmePhe8-substance P (6-11)

    A neuropeptide antagonist
  20. GC49251 Oxaliplatin-d10

    Lipoxal-d10

    An internal standard for the quantification of oxaliplatin
  21. GC49228 Ganoderol B

    灵芝醇 B; Ganodermadiol

    A triterpenoid with diverse biological activities
  22. GC49223 2-deoxy-D-Glucose-13C6

    2-DG-13C6

    An internal standard for the quantification of 2-deoxy-D-glucose
  23. GC49221 QLT0267 An ILK inhibitor
  24. GC49189 (E/Z)-4-hydroxy Tamoxifen-d5

    Afimoxifene-d5, 4-OHT-d5

    An internal standard for the quantification of (E/Z)-4-hydroxy tamoxifen
  25. GC49177 Loliolide

    地芰普内酯

    A monoterpene lactone with diverse biological activities
  26. GC49168 Visnagin

    齿阿米素

    A furanochromone with diverse biological activities
  27. GC49164 DM4 (hydrate)

    Maytansinoid DM 4

    A derivative of maytansine
  28. GC49155 K6PC-5 An SPHK1 activator
  29. GC49153 Didemnin B

    NSC 325319, NSC 333841

    Didemnin B 是一种由海洋被囊类动物产生的环状肽肽,可特异性结合 EEF1A 的 GTP 结合构象,抑制其从核糖体 A 位点释放并防止随后的肽延伸。
  30. GC49152 Celecoxib Carboxylic Acid

    羧酸塞来昔布

    An inactive metabolite of celecoxib
  31. GC49147 Carboxyphosphamide

    CPCOOH, NSC 145124

    An inactive metabolite of cyclophosphamide
  32. GC49137 Triclabendazole-13C-d3

    CGA89317-13C,d3

    An internal standard for the quantification of triclabendazole
  33. GC49130 Hydroxy Celecoxib

    羟甲基塞来昔布

    An inactive metabolite of celecoxib
  34. GC49127 4-oxo Cyclophosphamide

    4-keto CP, 4-keto Cyclophosphamide, NSC 139488, 4-oxo CP

    An inactive metabolite of cyclophosphamide
  35. GC49126 Folitixorin

    5,10-亚甲基四氢叶酸(非对映体混合物),5,10-Methylenetetrafolate; ANX-510 free acid

    Folitixorin是叶酸的一种还原形式,也是胸苷酸合成酶的辅助因子。
  36. GC49096 Cobaltic Protoporphyrin IX (chloride)

    原卟啉氯化钴

    An inducer of HO-1 activity
  37. GC49084 PHY34 An inhibitor of late-stage autophagy
  38. GC49080 CAY10786

    GPR52-IN-43

    A GPR52 antagonist
  39. GC49055 Tebuconazole-d9

    戊唑醇 d9

    An internal standard for the quantification of tebuconazole
  40. GC49042 Benastatin A A bacterial metabolite with diverse biological activities
  41. GC49024 Palmitic Acid MaxSpec® Standard

    棕榈酸

    A long-chain saturated fatty acid
  42. GC49023 Palmitic Acid-d9 MaxSpec® Standard

    棕榈酸-13,13,14,14,15,15,16,16,16-D9

    A quantitative analytical standard guaranteed to meet MaxSpec identity, purity, stability, and concentration specifications
  43. GC49015 Phenethyl isothiocyanate

    2-苯基乙基异硫代氰酸酯

    An isothiocyanate with anticancer activity
  44. GC48974 Ac-VEID-AMC (ammonium acetate salt)

    NAcetylValGluIleAsp7amido4Methylcoumarin, Caspase6 Substrate (Fluorogenic)

    A caspase-6 fluorogenic substrate
  45. GC48971 AZD 1152 (hydrochloride)

    5-[[7-[3-[乙基[2-(磷酰氧基)乙基]氨基]丙氧基]-4-喹唑啉基]氨基]-N-(3-氟苯基)-1H-吡唑-3-乙酰胺二盐酸盐

    A prodrug for a potent Aurora B inhibitor
  46. GC19843 Nimbolide

    印苦楝内酯

    An anticancer phytochemical
  47. GC62716 MD-222 MD-222 是一种首创的高效的基于 PROTAC 的 MDM2 降解剂。MD-222 诱导 MDM2 蛋白快速降解并激活细胞中的野生型 p53。MD-222 具有抗癌作用。
  48. GC62707 Murizatoclax

    AMG 397

    Murizatoclax (AMG 397) 是一种有效,选择性和具有口服活性的髓样白血病 1 (MCL-1) 抑制剂,Ki 值为 15 pM。Murizatoclax 与促凋亡 BCL-2 家族成员竞争性结合 MCL1 的 BH3 结合沟。Murizatoclax 可用于癌症的研究。
  49. GC62693 SCR130 SCR130 is a novel DNA repair inhibitor with IC50s of 14 μM in Reh cells and 2 μM in Nalm6 cells. SCR130 specifically inhibits DNA Ligase IV‐mediated joining with minimal or no effect on Ligase III and Ligase I mediated joining.
  50. GC62688 PD-1/PD-L1-IN-8

    PD-1/PD-L1-IN-8

    INCB086550 (PD-1/PD-L1-IN-8) is potent a PD-1/PD-L1 inhibitor, with an IC50 <= 10 nM.

  51. GC62682 BMSpep-57 hydrochloride BMSpep-57 hydrochloride 是一种有效的大环肽类抑制剂,抑制 PD-1/PD-L1 相互作用,IC50 为 7.68 nM。BMSpep-57 hydrochloride 与 PD-L1 结合,MST 和 SPR 测定表明,Kd 分别为 19 nM 和 19.88 nM。BMSpep-57 hydrochloride 通过增加 PBMC 中 IL-2 的产生促进 T 细胞功能。

Items 651 to 700 of 2733 total

per page

Set Descending Direction